Outcomes of Patients Not Responding to Antibiotics in the Community
NCT00245427 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2007-10-31
Summary
A study to report the outcomes of patients who fail to respond to beta-lactam and macrolide antibiotics in the community
Conditions
- Sinusitis
- Bronchitis, Chronic
- Pneumonia, Bacterial
Interventions
- DRUG
-
all macrolide antibiotics
Varies based on antibiotic
- DRUG
-
all beta-lactam antibiotics
Varies based on antibiotic
Sponsors & Collaborators
- collaborator INDUSTRY
-
CPL Associates
lead OTHER
Principal Investigators
-
Jerome J Schentag, Pharm.D. · State University of NY at Buffalo
-
Joseph Paladino, Pharm.D. · State University of NY at Buffalo
Study Design
- Allocation
- NON_RANDOMIZED
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Max Age
- 95 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-12-31
- Completion
- 2006-03-31
Countries
- United States
Study Locations
More Related Trials
-
Clinical Trial for the Assessment of Delayed Antibiotic Treatment Strategies
NCT01363531 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Neutrophil Extracellular Traps and Damage-associated Molecular Pattern Molecules on Long Term Use of Macrolides in Adults With Chronic Respiratory Disease
NCT05575726 ·Status: UNKNOWN
-
Prospective Clinical Evaluation of the FilmArray Respiratory Panel 2
NCT03012217 ·Status: COMPLETED
-
Use of MULTIplex PCR, Procalcitonin, and Sputum Appearance to Reduce Duration of Antibiotic Therapy During Severe COPD EXAcerbation: A Controlled, Randomized, Open-label, Parallel-Group, Multicenter Trial
NCT05280132 ·Status: RECRUITING ·Phase: NA
-
PCT-guided Treatment Regarding Antibiotic Use for Acute COPD Exacerbations
NCT05854901 ·Status: UNKNOWN ·Phase: NA
-
An Algorithm to Decide on Antibiotic Prescription in Lower Respiratory Tract Infection in Primary Care
NCT03191071 ·Status: COMPLETED ·Phase: NA
-
Combined Use of a Respiratory Broad Panel mPCR and Procalcitonin to Reduce Duration of Antibiotics Exposure in Patients With Severe Community-Acquired Pneumonia
NCT03452826 ·Status: COMPLETED ·Phase: NA
-
Procalcitonin Guided Antibiotic Therapy and Hospitalisation in Patients With Lower Respiratory Tract Infections: The "ProHOSP" Study
NCT00350987 ·Status: COMPLETED ·Phase: NA
-
Bronchiectasis and Long Term Azithromycin Treatment
NCT00415350 ·Status: COMPLETED ·Phase: PHASE3
-
Bacterial Colonization in COPD in View of CAT Under ICS+LABA Therapy
NCT01819298 ·Status: COMPLETED
-
Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 4.
NCT01224977 ·Status: UNKNOWN ·Phase: NA
-
Ceftobiprole in Hospital Acquired Pneumonia
NCT00229008 ·Status: COMPLETED ·Phase: PHASE3
-
Anti-inflammatory Action of Oral Clarithromycin in Community-acquired Pneumonia
NCT04724044 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective, Multicenter, Single-arm MAC-PD Cohort: a NTM-NET and ESGMYC Collaborative Study
NCT05906316 ·Status: RECRUITING
-
CRP-guided Antibiotic Treatment in COPD Exacerbations Admitted to the Hospital
NCT01232140 ·Status: UNKNOWN ·Phase: NA
-
PROcalcitonin Pneumonia / Pneumonitis Associated With ASPIration
NCT02862314 ·Status: COMPLETED ·Phase: PHASE4
-
Investigating the Impact of Sepsis Phenotypes on Antibiotic Treatment in Patients With Severe Pneumonia and Sepsis
NCT06977165 ·Status: NOT_YET_RECRUITING
-
Definition of Sub-phenotypes of Pneumonia Based on the Respiratory Microbiome Composition to Predict Microbial and Clinical Treatment Failures
NCT06916481 ·Status: RECRUITING
-
Comparison of Two Antibiotic Regimens for the Treatment of Early Airways Infection With PA in Adults With Bronchiectasis
NCT06368804 ·Status: RECRUITING ·Phase: PHASE2
-
Role of Pseudomonas Aeruginosa Biofilms in Exacerbations in Patients With Bronchiectasis With and Without Chronic Obstructive Pulmonary Disease
NCT04803695 ·Status: UNKNOWN
-
Azithromycin Microspheres in Patients With Low Risk Community Acquired Pneumonia
NCT00140023 ·Status: COMPLETED ·Phase: PHASE3
-
Use of a Biofilm Antimicrobial Susceptibility Assay to Guide Antibiotic Therapy
NCT00786513 ·Status: COMPLETED ·Phase: PHASE2
-
Polycolistin E Sodium Mesylate Combined With Intravenous Atomization for Carbapenem Resistant Gram-negative Bacteria in Pulmonary Infection
NCT06907069 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Improving P. Aeruginosa Detection With Breath-based Diagnostics (IMPACT-Breath)
NCT04735952 ·Status: RECRUITING
-
Pulmonary Microbiota in Patients With Chronic Obstructive Pulmonary Disease Colonized With P. Aeruginosa Resistant to Imipenem
NCT03008746 ·Status: COMPLETED ·Phase: NA